US2005074882A1PendingUtilityA1
Methods and products related to metabolic interactions in disease
Est. expiryApr 17, 2018(expired)· nominal 20-yr term from priority
Inventors:Martha Karen Newell
A61K 2039/505C07K 14/70532G01N 33/56977A61K 2039/57G01N 33/5005A61P 35/00A61K 35/12A61K 38/217A61K 38/1825C07K 14/70539C07K 14/47
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention involves methods of regulating cell growth and division to control disease processes by manipulating mitochondrial metabolism and the expression of cell surface immune proteins. The invention also involves related compositions and screening assays.
Claims
exact text as granted — not AI-modified1 - 142 . (Cancelled)
143 . A method of inducing tumor cell death, comprising administering to a subject, a therapeutically effective amount of an anti-HLA-DR antibody effective to induce tumor cell death in HLA-DR-expressing tumor cells.
144 . The method of claim 143 wherein the therapeutic outcome of the subject is improved following said administration.
145 . The method of treating cancer according to claim 144 wherein said cancer is selected from the group consisting of multiple myeloma, lymphoma's including Hodgkin's lymphomas, lymphocytic lymphomas and leukemias.
146 . The method of claim 144 wherein the anti-HLA-DR antibody is administered intravenously.
147 . The method of claim 144 wherein the anti-HLA-DR antibody is administered parenterally.Join the waitlist — get patent alerts
Track US2005074882A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.